Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy
Kristy R. Stengel, Scott W. Hiebert
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 51-65
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Genes (2020) Vol. 11, Iss. 5, pp. 556-556
Open Access | Times Cited: 267
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Joshua P. Smalley, Grace E. Adams, Christopher J. Millard, et al.
Chemical Communications (2020) Vol. 56, Iss. 32, pp. 4476-4479
Open Access | Times Cited: 94
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access | Times Cited: 1
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
Rahma K. Alseksek, Wafaa S. Ramadan, Ekram Saleh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8141-8141
Open Access | Times Cited: 32
Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification
N. Sanjib Banerjee, D. Moore, Thomas R. Broker, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 47
Open Access | Times Cited: 58
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies
Geoffrey M. Matthews, Parinaz Mehdipour, Leonie A. Cluse, et al.
Blood (2015) Vol. 126, Iss. 21, pp. 2392-2403
Open Access | Times Cited: 53
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms
Maria Pinkerneil, Michèle J. Hoffmann, René Deenen, et al.
Molecular Cancer Therapeutics (2016) Vol. 15, Iss. 2, pp. 299-312
Open Access | Times Cited: 53
Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
Kelly N. Hassell
Diseases (2019) Vol. 7, Iss. 4, pp. 57-57
Open Access | Times Cited: 53
Acetylation of 53BP1 dictates the DNA double strand break repair pathway
Xiang Guo, Yongtai Bai, Meimei Zhao, et al.
Nucleic Acids Research (2017) Vol. 46, Iss. 2, pp. 689-703
Open Access | Times Cited: 52
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma
Yueshuo Li, Chenxing Yang, Longlong Xie, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Histone Deacetylase 3 Is Required for Efficient T Cell Development
Kristy R. Stengel, Yue Zhao, Nicholas J. Klus, et al.
Molecular and Cellular Biology (2015) Vol. 35, Iss. 22, pp. 3854-3865
Open Access | Times Cited: 49
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
Clare M. Adams, Scott W. Hiebert, Christine M. Eischen
Cancer Research (2015) Vol. 76, Iss. 3, pp. 736-748
Open Access | Times Cited: 47
Clinical Efficacy and Mechanistic Insights of FDA-Approved HDAC Inhibitors in the Treatment of Lymphoma
Nasreddine El Omari, Saad Bakrim, Hamza Elhrech, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107057-107057
Open Access
Deacetylation Mechanism of Histone Deacetylase 8: Insights from QM/MM MP2 Calculation
Rui Lai, Hui Li
Physical Chemistry Chemical Physics (2025)
Closed Access
Replication stress response in cancer stem cells as a target for chemotherapy
Gwenola Manic, Antonella Sistigu, Francesca Corradi, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 31-41
Closed Access | Times Cited: 36
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer
Vijayalaxmi Gupta, Jeff Hirst, Shariska Petersen, et al.
Gynecologic Oncology (2021) Vol. 162, Iss. 1, pp. 163-172
Open Access | Times Cited: 26
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma
Bei Hu, Anas Younes, Jason R. Westin, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 59, Iss. 4, pp. 863-870
Closed Access | Times Cited: 29
HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids
Alexis Gonneaud, Naomie Turgeon, Christine M. Jones, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity
Rui Xie, Yan Li, Pingwah Tang, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 18, pp. 4415-4420
Open Access | Times Cited: 28
The multifunctional protein PACS-1 is required for HDAC2- and HDAC3-dependent chromatin maturation and genomic stability
Chinnadurai Mani, Kaushlendra Tripathi, Shan Luan, et al.
Oncogene (2020) Vol. 39, Iss. 12, pp. 2583-2596
Open Access | Times Cited: 21
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
Michèle J. Hoffmann, Sarah Meneceur, Katrin Hommel, et al.
Genes (2021) Vol. 12, Iss. 2, pp. 260-260
Open Access | Times Cited: 18
Maspin expression in prostate tumor elicits host anti-tumor immunity
Sijana H. Dzinic, Kang Chen, Archana Thakur, et al.
Oncotarget (2014) Vol. 5, Iss. 22, pp. 11225-11236
Open Access | Times Cited: 22
Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development
Kristy R. Stengel, Kelly R. Barnett, Jing Wang, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 32, pp. 8608-8613
Open Access | Times Cited: 22
Compromised global embryonic transcriptome associated with advanced maternal age
Blair R. McCallie, Jason C. Parks, G. Devon Trahan, et al.
Journal of Assisted Reproduction and Genetics (2019) Vol. 36, Iss. 5, pp. 915-924
Open Access | Times Cited: 20
Predict long-range enhancer regulation based on protein–protein interactions between transcription factors
Hao Wang, Binbin Huang, Jianrong Wang
Nucleic Acids Research (2021) Vol. 49, Iss. 18, pp. 10347-10368
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top